Loading...

FITC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103205 50 µg 24€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103206 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  2. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  3. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  4. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  5. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  6. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  7. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  8. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  9. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  10. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  11. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  12. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  13. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  14. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  15. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  16. Zaman R, et al. 2021. Immunity. :. PubMed
  17. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  18. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  19. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  20. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  21. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  22. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  23. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  24. Israelow B, et al. 2020. bioRxiv. . PubMed
  25. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  26. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  27. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  28. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  29. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  30. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  31. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  32. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  33. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  34. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  35. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  36. Dong L, et al. 2021. Cancer Cell. . PubMed
  37. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  38. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  39. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  40. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  41. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  42. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  43. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  44. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  45. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  46. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  47. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  48. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  49. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  50. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  51. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  52. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  53. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  54. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  55. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  56. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  57. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  58. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  59. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  60. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  61. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  62. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  63. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  64. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  65. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  66. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  67. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  68. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  69. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  70. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  71. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  72. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  73. Köchl R, et al. 2020. Elife. 9:00. PubMed
  74. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  75. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  76. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  77. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  78. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  79. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  80. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  81. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  82. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  83. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  84. Hutter K, et al. 2020. FEBS J. . PubMed
  85. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  86. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  87. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  88. Roy K, et al. 2019. Immunity. 50:616. PubMed
  89. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  90. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  91. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  92. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  93. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  94. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  95. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  96. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  97. Li H, et al. 2020. Nature. 584:274. PubMed
  98. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  99. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  100. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  101. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  102. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  103. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  104. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  105. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  106. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  107. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  108. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  109. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  110. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  111. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  112. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  113. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  114. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  115. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  116. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  117. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  118. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  119. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  120. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  121. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  122. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  123. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  124. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  125. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  126. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  127. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  128. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  129. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  130. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  131. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  132. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  133. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  134. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  135. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  136. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  137. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  138. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  139. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  140. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  141. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  142. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  143. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  144. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  145. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  146. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  147. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  148. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  149. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  150. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  151. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  152. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  153. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  154. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  155. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312991 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about PTPRC on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Fire™ 780 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark YG™ 593 anti-mouse/human CD45R/B220 (Flexi-Fluor™) Antibody RA3-6B2 FC
PE/Fire™ 744 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account